Todd - Are you talking about another cash raise where we all bitch and moan about the dilution and then after we hash it out for 2 weeks we somehow find a way to convince ourselves that it was actually a positive thing and the future never looked brighter? We don't even get a 24hr period of joyfulness with this stock. No matter what good news we get, we are lucky if the PPS goes up or that any pop (i.e. FDA approval) lasts more than 24 hours. Think about it - Reduce-IT results are outstanding (not so fast, what about the mineral oil), expedited review(hang on, there's an AdCom coming), FDA approval (slow down Bucky, did you forget about the patent suit), It's one thing after another coupled with nonstop FUD, dilutions, scheduled stock option exercises, complete air balls of judgement (patent case), lack of strategy (Europe), marketing missteps (absurd post approval ad campaign and lack of DTC ads- don't blame FDA - somebody at Amarin dropped the ball or intentionally delayed it.). And here we sit waiting out another binary event while the PPS languishes with arguably a drug that would save way more lives than a COVID-19 vaccine. I know, I know "Why don't you sell it then" - At this time, I have to see it to the end no matter what. I swear the PBS show Frontline will end up doing an expose on this when it is all over - I can just hear that narrators voice "meanwhile company executives were actively shorting the stock after the FDA win" :)
News 
Market Data 
Discover 
